Mitral Valve Prolapse (MVP) is a prevalent cardiovascular condition characterized by an abnormal closure of the mitral valve, the valve situated between the heart's left atrium and ventricle. In MVP, the valve's leaflets exhibit an unusual bulging or backward collapse into the atrium, leading to blood regurgitation. While some individuals with MVP remain asymptomatic, others may present with symptoms such as chest discomfort, palpitations, or persistent fatigue. The precise etiology of MVP is often elusive, although it can be linked to certain connective tissue disorders. Echocardiography is the primary diagnostic tool for evaluating MVP, enabling a detailed assessment of the mitral valve's structure and functionality. Treatment is generally unnecessary for those without symptomatic manifestations, but individuals with severe cases might be advised to undergo medication therapy. In rare instances, surgical intervention may be considered to repair or replace the affected valve. Regular monitoring and consistent communication with healthcare providers are crucial for the effective management of Mitral Valve Prolapse.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt